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We previously reported that Staphylococcus aureus avoids killing in macrophages by 
exploiting the action of Toll-like receptor (TLR) 2 that leads to the c-Jun N-terminal kinase 
(JNK)-mediated inhibition of superoxide production.  To search for bacterial components 
responsible for this event, a series of S. aureus mutants, in which the synthesis of cell wall 
was interrupted, were screened for the level of JNK activation in macrophages.  Besides a 
mutant lacking the putative TLR2 ligand, lipoproteins, two mutant strains were found to 
activate the phosphorylation of JNK to a lesser extent than the parental strain, and this defect 
was recovered by acquisition of the corresponding wild-type genes.  Macrophages that had 
phagocytosed the mutant strains produced more superoxide than those engulfing the parental 
strain, and the mutant bacteria were more efficiently killed in macrophages than the parent.  
The genes mutated, dltA and tagO, encoded proteins involved in the synthesis of D-alanylated 
wall teichoic acid.  Unlike a cell wall fraction rich in lipoproteins, D-alanine-bound wall 
teichoic acid purified from the parent strain by itself did not activate JNK phosphorylation in 
macrophages.  These results suggested that D-alanylated wall teichoic acid of S. aureus 
modulates the cell wall milieu for lipoproteins so that they effectively serve as a ligand for 
TLR2. 
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Invading microbial pathogens compete with host organisms in the regulation of innate 
immunity.1–5  They try to circumvent host immune responses to achieve an effective 
infection and prolonged survival through, for example, inhibition of signaling pathways for 
the activation of nuclear factor (NF)-κB and mitogen-activated protein kinases, which induce 
the transcription of genes coding for antimicrobial substances and pro-inflammatory 
cytokines.1–3  Some bacteria evade phagocytosis by immune cells or do not even concede 
once phagocytosed: they inhibit phagosomal maturation or escape from phagosomes to avoid 
digestion by lysosomal enzymes.6  To overcome such microbial actions against immune 
responses, host immune cells adopt an alternative strategy, as exemplified by the induction of 
autophagy, in which cytoplasmic bacteria are resealed with membranes and subjected to 
lysis.7–9  It is important to clarify the mechanism underlying the combat between microbial 
pathogens and host organisms for developing novel and effective medicines against infectious 
diseases. 
 We previously reported that Staphylococcus aureus inhibits the production of 
superoxide in macrophages to evade killing after phagocytosis, through Toll-like receptor 
(TLR) 2-mediated phosphorylation of c-Jun N-terminal kinase (JNK).10  This is unique in 
that bacteria exploit the actions of innate immune receptors that recognize microbial 
pathogens, TLR2 in this case, for their survival in macrophages.  Presumably, TLR2 is 
activated by a component(s) of S. aureus residing at the cell wall, such as lipoproteins and 
lipopeptides11–17 with some controversies18, to transmit a signal leading to the phosphorylation 
of JNK and subsequent inhibition of superoxide production in macrophages.  In the present 
study, we took a genetic approach to search for additional bacterial components required for 
the exploitation of TLR2 by S. aureus and obtained evidence that genes responsible for the 































































synthesis of D-alanylated wall teichoic acid (WTA) play a crucial role. 
 
Materials and methods 
 
Materials 
An antibody (#9251) specifically recognizing the phosphorylated form of JNK and another 
(#9252) recognizing both the phosphorylated and unphosphorylated forms were purchased 
from Cell Signaling Technology (Beverly, MA).  Using these antibodies, two isoforms of 
JNK with Mr of 46 and 54 kDa, and their phosphorylated forms were detectable.  
pHY300PLK, an Escherichia coli-S. aureus shuttle vector containing a tetracycline-resistant 
gene, was obtained from Takara-Bio (Ohtsu, Japan).  Fluorescein isothiocyanate was 
purchased from Molecular Probes (Eugene, OR); the synthetic lipopeptide 
tripalmitoyl-S-glycerylcysteine (Pam3Cys), lipopolysaccharide (LPS) from Salmonella 
enteritidis, and N-acetyl-L-cysteine were from Sigma-Aldrich (St. Louis, MO); mannitol salt 
agar medium was from Nissui (Tokyo, Japan); Diogenes was from National Diagnostics 
(Atlanta, GA); and the Dual Luciferase Assay kit was from Promega Corp. (Madison, WI). 
 
Generation of bacterial strains, bacterial culture, and preparation and maintenance of 
animal cells 
Cell surface mutants of S. aureus are derivatives of the parental wild-type S. aureus strain 
RN4220 (a derivative of NCTC8325-4, a restriction and agr mutant19) (Table 1).  To 
construct the mutant strains M0614 and M0615, sequences corresponding to portions of the 
SA0614 and SA0615 genes (nucleotide positions 50–400 and 32–507, respectively, with the 
first nucleotide of the translation start codon numbered as 1) were amplified by PCR and 
inserted into the S. aureus integration vector pSF151.20  RN4220 was then transformed with 































































the resulting plasmids pSFSA0614 and pSFSA0615, and M0614 and M0615 where the 
cognate genes had been disrupted by homologous recombination were selected.  RN4220 
and all the mutant strains were grown with Luria-Bertani medium at 37˚C (except for M0702 
that was grown at 30˚C) to full growth, washed once with PBS, and used in the subsequent 
experiments.  Macrophages from the peritoneal cavity of thioglycollate-injected C57BL/6 
mice were prepared and maintained with RPMI1640 medium supplemented with 10% (v/v) 
heat-inactivated fetal bovine serum at 37˚C with 5% (v/v) CO2 in air.21  Mice carrying 
disrupted tlr2 in a C57BL/6 background22 were provided by Dr. Shizuo Akira of Osaka 
University.  HEK293 cells were cultured in DMEM supplemented with 10% heat-inactivated 
fetal bovine serum at 37˚C with 5% CO2 in air.  All the experiments involving animals were 
conducted according to protocols that had been approved by the Committee on Animal 
Experimentation of Kanazawa University. 
 
Preparation of WTA and lipoproteins 
WTA of S. aureus that retained D-alanine was prepared as described below.  Bacteria were 
disrupted using glass beads and centrifuged at 800 × g for 10 min.  The supernatants were 
re-centrifuged at 20,000 × g for 10 min, and the precipitates were suspended with 20 mM 
sodium citrate (pH4.7) containing 0.5% (w/v) SDS, heated at 60°C for 30 min, and centrifuged 
at 20,000 × g for 10 min.  The precipitates were suspended with 5% (w/v) trichloroacetic 
acid, kept at room temperature for 18 h, and centrifuged at 20,000 × g for 10 min.  The 
supernatants were mixed with acetone, and the resulting precipitates were dissolved with 
water and centrifuged as above.  The final supernatants were collected as purified WTA.  
The purity of this WTA preparation was determined based on the amount of phosphorus 
contained in a given dry weight as well as by PAGE followed by staining with silver, 
according to standard procedures.23,24  To examine the attachment of D-alanine, the WTA 































































preparation was incubated with 0.1 M NaOH at 37˚C for 2 h and separated in thin-layer 
chromatography on Silica-gel 60 with a solvent of n-propanol : pyrdine : acetic acid : water = 
18 : 10 : 5 : 16, and the developed plate was treated with the ninhydrin reagent to visualize 
amino groups.  A fraction rich in lipoproteins was prepared by the Triton X-114 
phase-partitioning method, as described previously.14  Briefly, cell lysates were treated with 
Triton X-114 (2% (v/v)) and centrifuged at 10,000 × g for 10 min at 37˚C, and materials in 
the Triton X-114 phase were precipitated with ethanol, dissolved with water, and used as the 
lipoprotein-rich fraction. 
 
Assays for JNK phosphorylation, phagocytosis of S. aureus, colony formation of engulfed S. 
aureus, superoxide production, and lysosomal enzyme 
The level of phosphorylated JNK was determined by Western blotting as described.10  In 
brief, mouse peritoneal macrophages from either wild-type or tlr2-deficient mice were 
incubated with S. aureus (macrophages : bacteria = 1 : 5, except for wild-type macrophages 
with tagO and lgt mutants at a ratio of 1 : 10) or cell wall components at 37˚C and lysed in a 
buffer containing SDS and inhibitors of phosphatases and proteases, and the lysates were 
subjected to SDS-PAGE.  The separated proteins were transferred to polyvinylidene 
difluoride membranes and reacted with antibodies, and specific signals were visualized by a 
chemiluminescence reaction and processed using Fluor-S MultiImager (Bio-Rad, Hercules, 
CA).  Phagocytosis reactions with peritoneal macrophages and fluorescein 
isothiocyanate-labeled S. aureus as the phagocytes and targets (macrophages : bacteria = 1 : 
10), respectively, were carried out as described previously.10  After incubation, the 
macrophage cultures were washed with PBS to remove unengulfed bacteria, and macrophages 
attached to culture containers were fixed and treated with trypan blue for quenching 
fluorescence from bacteria remaining attached to macrophages.  The samples were then 































































examined by phase-contrast and fluorescence microscopy for the level of phagocytosis.  To 
determine the values of colony-forming units of engulfed S. aureus, macrophages incubated 
with bacteria (macrophages : bacteria = 1 : 500) for 30 min were washed to remove 
unengulfed bacteria and further incubated for 30 min.  The macrophages 0 and 30 min after 
the wash were lysed with water, and the lysates at serial dilutions were seeded on 
agar-solidified mannitol salt medium or Luria-Bertani medium, the latter of which contained 
tetracycline and was used for bacteria transformed with pHY300PLK-based plasmid.  The 
plates were incubated overnight at 37˚C, and the number of colonies (only those surrounded 
by yellow rings with mannitol salt medium) was determined and presented relative to that 
obtained at time 0 after the wash.  For the examination of superoxide production, 
macrophages maintained on coverslips with serum-free RPMI1640 medium were incubated 
with unlabeled bacteria (macrophages : bacteria = 1 : 1000) at 37˚C, and the amount of 
superoxide released into the culture medium was determined by a chemiluminescence 
reaction using Diogenes, as described previously.10  For determining the activity of 
α-N-acetylglucosaminidase, whole-cell lysates of peritoneal macrophages were incubated 
with a reaction mixture containing 4-methylumbelliferyl N-acetyl-α-D-glucosaminide 
(Sigma-Aldrich), and the level of cleaved substrates was measured with a fluorometer, as 
described previously.25 
 
Assay for NF-κB activation 
HEK293 cells were transfected by the calcium/phosphate method overnight with a mixture of 
plasmid DNA including pELAM26 (a gift from Dr. Douglas Golenbock at University of 
Massachusetts), a reporter gene vector expressing firefly luciferase under the control of a 
promoter activated by NF-κB; pRL-TK (Promega Corp.), a control reporter constitutively 
expressing Renilla luciferase used for the normalization of transfection efficiency; and mouse 































































TLR2 cDNA in pDisplay (Invitrogen, Carlsbad, CA) (a gift from Dr. Yoshiyuki Adachi at 
Tokyo University of Pharmacy and Life Science).27  The cells were further cultured with 
fresh medium for a day and subsequently incubated with S. aureus for 2 h, and the cell lysates 
were examined for the amounts of firefly luciferase and Renilla luciferase using the Dual 
Luciferase Assay kit.  The ratio of firefly luciferase to Renilla luciferase was determined and 
considered as the level of NF-κB activation. 
 
Statistical analysis 
Data are representative of at least 3 independent experiments (n = 2–3 in each experiment) 
that yielded similar results.  Data from quantitative analyses are expressed as the mean ± 
standard deviations of the results from at least 3 independent experiments.  Statistical 
analyses were performed using Student’s t-test, and P values of less than 0.05 were 





Inefficient JNK phosphorylation in macrophages after incubation with S. aureus lacking 
expression of dltA or tagO 
To search for components of S. aureus responsible for the activation of TLR2-mediated 
phosphorylation of JNK in macrophages, we screened a series of S. aureus strains with 
mutations that affect the structure of cell wall (Table 1).  Peritoneal macrophages from 
thioglycollate-injected mice were incubated with either the parental strain RN4220 or its 
mutant strains, and whole cell lysates were subjected to Western blotting to determine the 
level of the phosphorylated form of JNK.  Macrophages showed a rise in the level of 































































phosphorylated JNK 10 min after the incubation with RN4220, and the increase continued 
during the next 20 min (left panel in Fig. 1a), as we reported previously.10  Incubation with a 
mutant strain lacking the expression of dltA similarly brought about the activation of JNK 
phosphorylation, but the level was much lower than that observed with the parental strain (left 
panel in Fig. 1a).  This effect was not due to impaired phagocytosis of the mutant bacteria by 
macrophages because the parental and mutant strains were comparable in their susceptibility 
to phagocytosis (right panels in Fig. 1a).  The level of phosphorylated JNK was lower in 
macrophages incubated with the strain T013 (Fig. 1b), in which the lgt gene coding for 
lipoprotein diacylglycerol transferase is disrupted.14  This mutant strain is devoid of lipid 
modification of all lipoproteins at the cell surface, and the result was in line with previous 
reports that lipoproteins serve as a ligand for TLR2.  Similar reduction in the level of JNK 
phosphorylation was seen when macrophages were incubated with a tagO-deficient strain and, 
though less significantly, mutants for the genes SA0614 or SA0615 (Fig. 1b).  The other 
mutant strains including one deficient in the ltaS gene, which codes for 
polyglycerolphosphate synthase of lipoteichoic acid (LTA), did not differ from the parental 
strain as to the effect on the phosphorylation of JNK in macrophages (Fig. 1b).  When 
macrophages were incubated with the dltA mutant that had been introduced with a plasmid 
expressing the dltABCD operon, the level of phosphorylated JNK became almost equal to that 
in macrophages incubated with the parental strain (left panel in Fig. 1c).  Similarly, the 
expression of tagO in the tagO mutant complemented a defect in the phosphorylation of JNK 
(right panel in Fig. 1c).  These results confirmed the importance of dltA and tagO for S. 
aureus to induce JNK phosphorylation in macrophages. 
 
Auxiliary action of D-alanylated teichoic acid in the activation of TLR2 by S. aureus 
Unlike TLR4-acting LPS, the parent and mutant strains deficient in dltA or tagO did not seem 
to activate macrophages lacking the expression of TLR2 in terms of the induction of JNK 































































phosphorylation (Fig. 2a).  This indicated that the S. aureus-activated phosphorylation of 
JNK depends on the action of TLR2.  In fact, a fraction rich in lipoproteins, a putative ligand 
for TLR2, obtained from the parent strain, the dltA mutant, and the tagO mutant, but not from 
a mutant strain lacking the expression of lgt, induced the phosphorylation of JNK in wild-type 
macrophages (Fig. 2b). 
 The dltA gene codes for one of the proteins responsible for the D-alanylation of 
teichoic acids,28 and tagO codes for an enzyme responsible for the transfer of 
N-acetylglucosamine phosphate to the lipid carrier,28 an essential step in the synthesis of 
WTA.  On the other hand, SA0614 and SA0615 code for proteins that compose a 
two-component system of S. aureus, which induces the expression of the dltABCD 
operon.29,30  Considering the results with mutant strains deficient in these genes as well as 
one with the ltaS mutant lacking LTA, we anticipated that D-alanylated WTA is required for 
the TLR2-mediated phosphorylation of JNK in macrophages.  To more directly determine 
the role of WTA, we isolated WTA from S. aureus strains and examined its action.  The 
WTA preparation was considered to be nearly pure based on the content of phosphorus and 
the staining pattern in PAGE (left and middle panels in Fig. 2c): note that none was obtained 
from the tagO mutant lacking an enzyme essential for WTA synthesis, and that a difference in 
the migration of WTA prepared from the dltA mutant was probably due to a lack of D-alanine.  
In fact, WTA of the dltA mutant strain seemed to be devoid of D-alanine whereas that of the 
parental and the lgt mutant strains retained it (right panel in Fig. 2c).  When macrophages 
were incubated with these WTA preparations, the phosphorylation of JNK was not induced 
irrespective of the presence of bound D-alanine in WTA (Fig. 2d), indicating that WTA does 
not serve as a ligand for TLR2.  We next tested if WTA influences the action of the TLR2 
ligand.  To this end, macrophages were incubated with Pam3Cys, a synthetic TLR2 ligand, 
in the presence and absence of WTA.  However, the level of phosphorylated JNK was not 
altered by the addition of WTA (Fig. 2d).  These results suggested that D-alanylated WTA 































































serves as an auxiliary factor for the TLR2 ligand in the context of bacterial cell wall so that it 
effectively acts on TLR2 to induce the phosphorylation of JNK. 
 
Enhanced superoxide production and accelerated killing of engulfed bacteria in 
macrophages incubated with S. aureus deficient in dltA or tagO 
We next determined the level of superoxide production in S. aureus-incubated macrophages, 
which we previously showed to be inhibited by phosphorylated and thus activated JNK.10  
The level of superoxide released from macrophages into culture media was significantly 
higher on incubation with a mutant strain lacking the expression of dltA, tagO or lgt than with 
the parental strain (left panel in Fig. 3a).  The effect of the mutation in dltA was mitigated 
when the dltABCD operon was introduced into the mutant strain (right panel in Fig. 3a), 
confirming the requirement of dltA for the effective inhibition of superoxide production in 
macrophages by S. aureus.  The viability of engulfed S. aureus was then assessed based on 
their colony-forming ability.  The value of colony-forming units obtained with the dltA 
mutant was much smaller than that with the parental or the same mutant strain that had 
acquired the corresponding wild-type operon (Fig. 3b), indicating that S. aureus lacking the 
expression of dltA was more efficiently killed in macrophag s.  Furthermore, the dltA mutant 
survived the killing in macrophages when the cultures were supplemented with 
N-acetyl-L-cysteine, a superoxide scavenger (Fig. 3c).  We next examined if the recognition 
and engulfment of S. aureus alters the activity of macrophages other than superoxide 
production.  For this purpose, macrophages were incubated with various S. aureus stains, 
and their whole-cell lysates were assayed for α-N-acetylglucosaminidase, a major lysosomal 
enzyme.  However, its activity did not change after the incubation with any of the bacterial 
strains tested (Fig. 3d), suggesting that the lysosomal activity is not influenced by S. aureus.  
These results indicated that a lack of the expression of dltA or tagO in S. aureus causes 
augmented production of superoxide and accelerated killing of engulfed bacteria in 































































macrophages, and thus suggested a role for the D-alanylation of WTA in the survival of S. 
aureus in macrophages. 
 
Inefficient activation of NF-κB in TLR2-expressing cells incubated with S. aureus 
lacking dltA or tagO 
We next determined the level of NF-κB-dependent gene expression in TLR2-expressing 
HEK293 cells, examining a role for dltA and tagO in the activation of TLR2.  The 
expression of a NF-κB-induced gene coding for luciferase depended on the presence of TLR2 
in HEK293 cells as well as the addition of S. aureus to them (Fig. 4a), indicating that the level 
of active NF-κB reflects the activation of TLR2-initiated signaling by bacteria.  HEK293 
cells incubated with the dltA mutant produced much less luciferase than those treated with the 
parental strain, and this decrease was recovered when the dltABCD operon was introduced 
into the mutant (Fig. 4b).  A decrease in the level of active NF-κB was similarly observed 
when the mutants for tagO, SA0614, and SA0615, which all gave a reduced level of 
phosphorylated JNK in macrophages (see Fig. 1b), were tested (Fig. 4c).  In contrast, the 
other mutant strains with no effect on the phosphorylation of JNK activated NF-κB as 
effectively as the parental strain (Fig. 4c).  These results suggested that D-alanylated WTA is 
required for S. aureus to effectively induce the TLR2-mediated activation of NF-κB. 
 
Taken together, the effects of dltA and tagO on JNK phosphorylation, superoxide production, 
the survival of engulfed bacteria, and the activation of TLR2-mediated signaling are 
consistent with the concept that a component of S. aureus, i.e. D-alanylated WTA, additional 
to an authentic ligand is required for TLR2 to effectively phosphorylate and activate JNK 
leading to the inhibition of superoxide production in S. aureus-engulfing macrophages. 
 

































































The study presented here showed that genes responsible for the synthesis and D-alanylation of 
teichoic acids are required for the TLR2/JNK-dependent survival of S. aureus in macrophages.  
The importance of D-alanylated LTA of S. aureus for the production of a pro-inflammatory 
cytokine by macrophages has been reported.31  However, our results clearly indicated that 
WTA, not LTA, is necessary for the TLR2-mediated phosphorylation of JNK.  There are 
preceding reports showing an in vivo role for the D-alanylation of teichoic acids of S. aureus32 
and Streptococcus gordonii33 in bacterial virulence and TLR2-mediated host defense.  Our 
study provides a reasonable explanation for the observation in these papers that bacteria 
evoking a higher level of immune response in host organisms are, at the same time, more 
infectious and virulent.  We also showed that the D-alanylation of teichoic acids is necessary 
for S. aureus to effectively activate NF-κB in TLR2-expressing cells.  It can thus be 
anticipated that D-alanylated WTA plays an important role in the TLR2-initiated signaling 
pathways in immune cells in favor of both host organisms and invading microbial pathogens.  
Purified WTA by itself did not induce JNK phosphorylation in macrophages, and 
exogenously added WTA was not effective on the phosphorylation of JNK induced by a 
synthetic ligand for TLR2.  Therefore, it is probable that D-alanylated WTA does not 
directly act on TLR2 as a ligand but facilitates the activation of TLR2 by an authentic ligand 
like lipoproteins or lipopeptides in the context of the bacterial cell wall.  There is a report 
showing that WTA mediates the interaction of S. aureus with airway epithelial cells.34  
However, this is not the case in our study because the level of the phagocytosis of S. aureus 
by macrophages does not differ between the parental and dltA mutant strains.  We speculate 
that WTA modulates the cell wall milieu for lipoproteins so that they effectively serve as a 
ligand for TLR2. 































































 The stimulation of JNK phosphorylation occurred when TLR2-lacking 
macrophages were incubated with LPS.  This suggests that the JNK-mediated inhibition of 
killing of engulfed bacteria is not restricted to TLR2-stimulating bacteria, S. aureus in our 
study, but is observed for the bacteria recognized by TLR4.  We previously reported that 
TLR4 delays the fusion between lysosomes and phagosomes that contain engulfed apoptotic 
cells.25  Other investigators have also reported the involvement of TLR in the regulation of 
phagosome maturation and thus the fate of engulfed materials including microbial pathogens, 
microbe-infected cells, and apoptotic cells.35–37  They argue that TLR-mediated control of 
phagosome maturation relates to the regulation of antigen presentation.38–41  It is thus 
obvious that TLRs, TLR2 and TLR4 in particular, participate in not only humoral but also 
cellular immune responses.  Further investigation will be necessary to obtain a complete 
picture that illustrates the mechanisms and consequences of TLR-mediated regulation of 
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Figure 1. Inefficient phosphorylation of JNK in macrophages incubated with S. aureus 
lacking the expression of D-alanylated WTA.  Mouse peritoneal macrophages were 
incubated with various S. aureus strains: the parental strain RN4220 (parent) and mutant 
strains lacking the expression of the indicated genes with the symbol ‘Δ’, and responses in 
macrophages were examined.  (a) Macrophages were incubated with the parental strain or 
the mutant strain deficient in dltA for the indicated periods (30 min for phagocytosis), and the 
levels of phosphorylated JNK and phagocytosis of bacteria were determined.  Arrowheads 
with the terms ‘P-JNK’ and ‘total’ denote the positions of the phosphorylated and both the 
phosphorylated and unphosphorylated forms of JNK, respectively.  (b, c) Macrophages were 
incubated with the indicated S. aureus strains for 30 min, and the level of phosphorylated 
JNK was determined.  In (c), the S. aureus strains used were the parental strain transformed 
with pHY300PLK alone (vector), ΔdltA transformed with pHY300PLK alone, ΔdltA 
transformed with dltABCD operon-expressing pHY300PLK (dltABCD), ΔtagO transformed 
with pHY300PLK alone, and ΔtagO transformed with tagO-expressing pHY300PLK (tagO). 
 
Figure 2. Absence of JNK phosphorylation in macrophages treated with D-alanylated WTA.  
(a) Peritoneal macrophages of tlr2-disrupted mice were incubated with the indicated S. aureus 
strains or LPS (0.1 mg/ml) for 30 min, and the level of phosphorylated JNK was determined.  
(b) Macrophages of wild-type mice were incubated with a fraction rich in lipoproteins (0.1 
µg/ml) obtained from the indicated S. aureus strains for 30 min, and the level of 
phosphorylated JNK was determined.  (c) WTA prepared from the indicated S. aureus 
strains was characterized: determination of the phosphorus content (left), PAGE of WTA 
visualized with silver (middle), and thin-layer chromatography of D-alanine alkali liberated 































































from WTA (visualized by the ninhydrin reaction) (right).  The arrowhead with ‘D-Ala’ in the 
right panel points to the position of D-alanine analyzed as a control.  (d) Wild-type 
macrophages were incubated for 15 min with and without Pam3Cys (1 µg/ml), a synthetic 
TLR2 ligand, and WTA (10 µg/ml) purified from the indicated S. aureus strains, and the level 
of JNK phosphorylation was determined. 
 
Figure 3. Increased production of superoxide and accelerated killing of engulfed bacteria in 
macrophages incubated with dltA-, tagO-, or lgt-deficient S. aureus.  Mouse peritoneal 
macrophages were incubated with S. aureus, and the levels of superoxide production and 
values of colony-forming units of engulfed bacteria were determined.  (a) Macrophages were 
incubated with the indicated S. aureus strains for 30 min, and the amount of superoxide in the 
culture medium was determined and presented relative (in percentage terms) to that in 
incubation with the parental strain RN4220 (left panel) or the dltA mutant transfected with the 
empty vector (right panel).  (b) The value of colony-forming units of the indicated S. aureus 
strains that had been engulfed by macrophages was determined 0 and 30 min after elimination 
of unengulfed bacteria and shown relative (in percentage terms) to that obtained at time 0.  
(c) Macrophages that had been pre-treated with N-acetyl-L-cysteine (LNAC) (2 mM) or left 
untreated at 37˚C for 1 h were incubated with the indicated strains, and the value of 
colony-forming units of engulfed bacteria was determined.  (d) Macrophages were incubated 
with the indicated S. aureus strains or left untreated (none), and their whole-cell lysates were 
assayed for the activity of α-N-acetylglucosaminidase at the indicated time points. 
 
Figure 4. Inefficient activation of NF-κB in TLR2-expressing cells incubated with 
dltA-deficient S. aureus.  (a) (left) HEK293 cells with and without TLR2 expression were 
incubated with RN4220 (HEK293 : bacteria = 1 : 103) or left untreated, and the level of 































































NF-κB activation was determined and shown relative to that in cells expressing TLR2 with no 
added bacteria, taken as 1.  (right) HEK293 cells (1 × 105) expressing TLR2 were incubated 
with increasing amounts of RN4220, and the level of NF-κB activation was determined and 
shown relative to that in the experiment with no added bacteria, taken as 1.  (b, c) HEK293 
cells expressing TLR2 were incubated with the indicated S. aureus strains (HEK293 : bacteria 
= 1 : 100), and the level of NF-κB activation was determined and shown relative (in 
percentage terms) to that in the experiment with the parental strain RN4220. 






























































Table 1. S. aureus strains and plasmids used in this study. 
 
      
Names Genotypes and characteristics References 
      
RN4220 NCTC8325-4, restriction mutant 19 
M0793 RN4220 dltA::pT0793 42 
M0702 RN4220 tagO::pT0702 42 
M0614 RN4220 SA0614::pSFSA0614 this study 
M0615 RN4220 SA0615::pSFSA0615 this study 
M0674/pM101 RN4220 ltaS::phleo/pM101 43 
M0875 RN4220 ypfP::pT0875 42 
JT1304 RN4220 atl::cat 44 
CK1001 RN4220 mprF::pCK20mprF 45 
M0107 RN4220 spa::phleo unpublished observation 
T013 RN4220 lgt::pMlgt 14 
      
pHY300PLK E. coli-S. aureus shuttle vector; Ampr Tetr purchased from Takara-Bio 
p0793 pHY300 with intact dltABCD from RN4220 42 
p0702 pHY300 with intact tagO from RN4220 42 
pSF151 S. aureus integration vector; Kmr 20 
pSFSA0614 pSF151 with partial SA0614 from RN4220 this study 
pSFSA0615 pSF151 with partial SA0615 from RN4220 this study 
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